復星醫藥(02196.HK)預計近期有一批疫苗運抵港澳用於後續接種安排
復星醫藥(02196.HK)公布,BioNTech至今就針對「210102」批次的疫苗產品中存在少量西林瓶封蓋有關瑕疵問題的調查,BioNTech確認該問題的出現與超低溫運輸條件下的疫苗包裝有關,疫苗的安全性和有效性不受到影響。
經詳細分析檢測數據和隨機抽樣測試,BioNTech認為沒有證據顯示新冠疫苗批次「210102」及「210104」 存在安全風險;由於疫苗儲存於超低溫環境,因此受到細菌污染的風險很低;即使藥瓶出現問題,有關疫苗的信使核糖核酸(mRNA)及脂質納米顆粒的完整性亦不會受到影響。基於上述結果,BioNTech認為疫苗的安全性及有效性並未受到影響。
為謹慎起見,在最終調查報告完成之前,「210102」及「210104」兩個批次的疫苗仍將繼續封存。
同時,集團與BioNTech將繼續配合中國香港及澳門政府疫苗接種計劃,保障疫苗的供應。預計近期將有一批由BioNTech位於德國的另一生產場地灌裝的疫苗產品運抵香港,用於香港、澳門的後續接種安排。
根據測試及對比結果顯示,當產品在超低溫儲存環境(即攝氏負70度)下儲存及運輸時,若軋蓋密封不夠緊,可能會導致空氣滲入瓶中,而其後進行解凍程序時膠塞重新恢復密封,可能會使瓶內壓力上升,因而發生個別藥瓶超壓或出現滲漏等情況。在同一場地灌裝的210104批次也有個別產品出現此類問題。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.